TB Research

Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system

Briner M, Oberholzer M, Wagner F, Chan A

BMJ case reports · 2021-08

Abstract

A 36-year-old man of central Asian origin was diagnosed with subacute disseminated tuberculosis. Initially, central nervous system involvement was suggested by an encephalopathic condition and MRI showing extensive basal and spinal meningitis. After initiation of anti-tuberculosis drugs and corticosteroid therapy, clinical and radiological deterioration of spinal damage was noted. We interpreted this in the context of a paradoxical reaction, which is suggested to be an overshooting inflammatory response after reconstitution of the immune system. Despite increased dosage of corticosteroids, a gradual worsening of gait ataxia over several weeks was noted. After administration of infliximab, the patient's condition progressively improved.

MeSH terms

  • Central Nervous System
  • Humans
  • Tuberculosis, Miliary
  • Adrenal Cortex Hormones
  • Antitubercular Agents
  • Adult
  • Immune Reconstitution Inflammatory Syndrome
  • Infliximab